At Bayer, we are deeply committed to forming partnerships in order to solve unmet needs. Our goal is to advance patient care through knowledge-sharing and collaboration. We’re relentlessly devoted to reducing burden of disease and delivering meaningful patient outcomes. #LeadingANormalLife #LessBurden #VisionInOphthalmology
Good and useful approach - to advance patient care through knowledge-sharing and collaboration…👍
Working to Fund A Cure #HSPandPLS Exe Dir, SP-Foundation.org / Pilot, MRPC GRR BOD
June 21-23, 2024! #TampaFL JOIN SP-Foundation make some NOISE for #spasticparaplegia. A rare disease group needs every member to help grow awareness. The 2024 SPF #HSPandPLS Annual Conference brings together patients, physicians, and researchers to really see YOU! Come share your story with others register online for in-person 21-23, 2024 or virtually! #hspandpls #spasticparaplegiafoundation #awarenesshspandpls #releasecures #curehspandpls #disabilityawareness #patientadvocate #patienteducation #findacure #championcures #releasecures
June 21-23, 2024! #TampaFL JOIN SP-Foundation make some NOISE for #spasticparaplegia. A rare disease group needs every member to help grow awareness. The 2024 SPF #HSPandPLS Annual Conference brings together patients, physicians, and researchers to really see YOU! Come share your story with others register online for in-person 21-23, 2024 or virtually! #hspandpls #spasticparaplegiafoundation #awarenesshspandpls #releasecures #curehspandpls #disabilityawareness #patientadvocate #patienteducation #findacure #championcures #releasecures
It’s time to be bold and redefine how virtual cardiopulmonary care is delivered. Join Wellinks at HLTH 2024 as we explore how Predictive Patient Care is transforming the future of cardiopulmonary disease management, empowering more people to breathe easier and live healthier. Let’s innovate together and pave the way for better outcomes in cardiopulmonary care! Want to learn more? Meet Stacie Bratcher (CEO), Aashish M. (EVP) and Patrick Sheehan (VP of Partnerships) at HEALTH 2024! #HLTH2024 #BeBold #PredictivePatientCare #Wellinks #HealthcareInnovation
It’s the FDA's virtual public meeting today, in global observance of Rare Disease Week. This event brings together patients, healthcare professionals, and industry leaders to discuss vital topics impacting rare disease research and treatment. We're looking forward to attending and gaining valuable insights to further our mission of improving patient outcomes. #RareDiseaseWeek #FDAEvent #RareDiseaseResearch #RareDiseaseAwareness
Chasta Posey, FSR Patient Advocate, Patient Navigator, Member of the FSR Women of Color Advisory Committee, and FSR Global Sarcoidosis Alliance Volunteer Leader, joined Tricha Shivas, FSR’s Chief Strategy Officer, and advocates from around the US as part of the Virtual Oxygen Hill Day on January 31, 2024, aimed at improving the lives of those impacted by lung disease. Read the blog to learn about Chasta's experience with sarcoidosis and being approved for oxygen, and why it's important to her to get legislators involved. Read here: https://loom.ly/uhDySLc #sarcoidosis #oxygenhillday #pulmonarysarcoidosis
Delighted to share insights from Lifebit's latest blog showcasing the vital role of patient registries in advancing rare disease research. Uncover the four key benefits propelling progress in healthcare solutions: https://bit.ly/49hJKlo #RareDisease #PatientRegistries #PrecisionMedicine #Lifebit
At AstraZeneca, we are continuing to follow the science to further unlock our understanding of complex immune-driven diseases like SLE. If we can recognize and address the underlying drivers of disease, we can tackle key areas of unmet need that remain. On #WorldLupusDay let’s shed light on the urgent need for higher standards of lupus care. Together, we can take action to advance the existing standard of care and help those with lupus lead fuller lives. #MakeLupusVisible #UnlockingLupus #WorldLupusDay #AstraZenecaEgypt
The tide is turning in lupus care, with recent updates to clinical guidelines highlighting remission as a key care goal. For patients, time in remission, free from symptoms, would be transformational. We are collaborating with the lupus community to make this possible. Learn more: https://learn.az/6040jqtD6 #WorldLupusDay #MakeLupusVisible
Digital Transformation | Omnichannel | Digital Marketing | Agile | Customer Engagement | e-commerce| Digital Health | Open innovation
At AstraZeneca, we are continuing to follow the science to further unlock our understanding of complex immune-driven diseases like SLE. If we can recognize and address the underlying drivers of disease, we can tackle key areas of unmet need that remain. On #WorldLupusDay let’s shed light on the urgent need for higher standards of lupus care. Together, we can take action to advance the existing standard of care and help those with lupus lead fuller lives. #MakeLupusVisible #UnlockingLupus #WorldLupusDay #AstraZenecaEgypt
The tide is turning in lupus care, with recent updates to clinical guidelines highlighting remission as a key care goal. For patients, time in remission, free from symptoms, would be transformational. We are collaborating with the lupus community to make this possible. Learn more: https://learn.az/6040jqtD6 #WorldLupusDay #MakeLupusVisible
Patient access programs thrive when they are supported by actionable data and the right technology. Learn how UBC’s success for rare disease patients is evolving and impacting patients: https://hubs.li/Q02zmC5z0 #PatientsFirst #PatientAccess #PatientSupport #RareDisease
Learn how MendelScan from Mendelian a rare disease case-finding platform, uses advanced technology to accelerate diagnosis and improve patient outcomes. Read here: https://lnkd.in/eT9HsnZR #AiForGood #TechForGood #RareDiseaseAI #MendelScan #DiagnosisTech #HealthTech #PrecisionMedicine #MedicalInnovation #HealthcareAI
Partnering with purpose driven organisations to improve access to quality eye health. #LoveYourEyes #2030InSight
3moBayer | Ophthalmology with over 10 years of impactful partnership, collaboration and knowledge sharing with International Agency for the Prevention of Blindness (IAPB) your actions are testment to your approach and commitement for advancing patient care - everywhere around the world.